Actinium Pharmaceuticals to Present Business Update at Trump Mar-A-Lago Club Today
Actinium Pharmaceuticals(ATNM) Prnewswire·2025-03-26 12:45- Company to highlight recent significant progress made with its Actimab-A and Iomab-ACT clinical programs, leading-edge R&D and radiopharmaceutical manufacturing infrastructure - Revitalized clinical programs focused on 3 separate multi-billion-dollar market opportunities in myeloid malignancies, solid tumors and cell & gene therapy conditioning with clinical data expected in 2025 supporting each addressable market - Presentation follows Investor KOL Event and Company Update on March 25th NEW YORK, March 2 ...